HKU Gets Green Light For Nasal Covid Vaccine Trials
"); jQuery("#212 h3").html("
"); });
2020-09-09 HKT 19:19
Share this story
The University of Hong Kong says mainland authorities have allowed clinical trials of a nasal spray vaccine for Covid-19 it has been developing with mainland institutions.
The State Key Laboratory of Emerging Infectious Diseases of the university's Department of Microbiology has been working on the vaccine with Xiamen University and Beijing Wantai Biological Pharmacy.
It says it is the only nasally-administered vaccine against the disease to be allowed for clinical trials so far by the National Medical Products Administration.
South Korea Unveils Digital Asset Basic Act For Stablecoin Issuance
South Korea’s newly elected President Lee Jae-myung is pushing forward with plans to allow stablecoin issuance by loc... Read more
Octopus Taps Wonder As Its Omnichannel Payment Partner Across Hong Kong
Wonder, a payment and fintech platform, has announced its partnership as the purported first omnichannel payment facili... Read more
China And UAE Ink Deal To Boost Cross-Border Payment Cooperation
China’s Cross-Border Interbank Payment System (CIPS) and the Central Bank of the United Arab Emirates (CBUAE) have si... Read more
Hong Kong Approves Banking Amendment To Boost Data Sharing In 2025
The Government welcomed the Legislative Council’s June 4 passage of the Banking (Amendment) Bill 2025, aimed at impro... Read more
Citigroup Lays Off 3,500 In China As Part Of Global Overhaul
Citigroup is cutting 3,500 tech jobs in mainland China to streamline operations and cut costs. The Citigroup China layo... Read more
Hong Kong Expands Crypto Market With Derivative Trading For Investors
Hong Kong’s Securities and Futures Commission (SFC) will soon introduce virtual asset derivatives trading for profess... Read more